6-K ·Filed Sep 15, 2026

NVO

NOVO NORDISK A S
NEUTRAL
Impact 3/10
Horizonimmediate Processed17d 10h ago SEC0001171843-26-006038
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for the actual content of this 6-K, as it may contain material updates on pipeline, regulatory, or financial matters. Without document content, no directional trade is warranted; await further disclosure or a subsequent filing with substantive details.

DirectionNeutral
Confidencelow
Horizonimmediate
Latest settled — T+5d
NVO ▼ -7.36% at T+5d
NEUTRAL call ✗ call lost -7.36% · α vs SPY -9.49% · entry $42.53 → $39.40
Next anchor: T+20d in 11d
Latest observation: T+8 -3.78% FF3 residual α
Entry anchored
Sep 15, 2026
via day open
T+1d
-1.93%
call -1.93% · α -1.49%
$41.71
settled 16d ago
T+5d
-7.36%
call -7.36% · α -9.49%
$39.40
settled 10d ago
T+20d
—
call — · α —
—
in 11d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. The filing is a Form 6-K submitted by Novo Nordisk A/S, which typically covers material information disclosed under foreign private issuer rules, but no substantive details could be extracted from the provided document.

Key Facts

  • Filing type: 6-K (foreign private issuer report)
  • Company: Novo Nordisk A/S (ticker NVO)
  • Document content was unavailable for analysis

Financial Impact

No financial figures available — document content was unavailable.

Risk Factors

  • Document content unavailable — potential for undisclosed material information
  • If the 6-K contains negative clinical or regulatory news, downside risk could be significant

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
31% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-006038
Document: 0001171843-26-006038-index-headers.html0001171843-26-006038
Document: 0001171843-26-006038-index.html0001171843-26-006038
Document: 0001171843-26-006038.txt0001171843-26-006038
26 reports for NVO
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +14.18%Jun 10, 2026
Filters
Rows
Reports for NVO — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
6-K
NEUTRAL ★ 3/10
$42.53 $39.40▼ −7.36%▼ −9.49%$37.32 (−12.25%)
Sep 9, 2026
23d ago
6-K
NEUTRAL ★ 2/10
$44.56 $41.71▼ −6.40%▼ −5.74%$37.32 (−16.25%)
Sep 8, 2026
24d ago
Court Ruling
NEUTRAL ★ 1/10
$45.16 $42.53▼ −5.82%▼ −4.70%$37.32 (−17.36%)
Sep 3, 2026
29d ago
Court Ruling
NEUTRAL ★ 1/10
$47.51 $43.07▼ −9.35%▼ −8.20%$37.32 (−21.45%)
Aug 24, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$46.92 $45.33▼ −3.39%▼ −3.86%$37.32 (−20.46%)
Aug 18, 2026
6w ago
6-K
NEUTRAL ★ 2/10
$45.71 $48.66▲ +6.45%▲ +6.65%$37.32 (−18.35%)
Aug 10, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$47.73 $44.88▼ −5.97%▼ −5.92%$37.32 (−21.81%)
Aug 10, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$47.73 $44.88▼ −5.97%▼ −5.92%$37.32 (−21.81%)
Aug 4, 2026
8w ago
6-K
MIXED ★ 6/10
$44.28 $47.17▲ +6.53%▲ +6.63%$37.32 (−15.72%)
Aug 4, 2026
8w ago
6-K
NEUTRAL ★ 2/10
$44.28 $47.17▲ +6.53%▲ +6.63%$37.32 (−15.72%)
Showing 10 of 26

US Market Status

Market Closed — Opens Mon (64h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access